Need professional-grade analysis? Visit stockanalysis.com
$6.29B
N/A
3,494
N/A
Jinxin Fertility Group Ltd (1951) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at HKD2.36, down 2.07% from the previous close.
Over the past year, 1951 has traded between a low of HKD2.18 and a high of HKD3.44. The stock has lost 22.4% over this period. It is currently 31.4% below its 52-week high.
Jinxin Fertility Group Ltd has a market capitalization of $6.29B.
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; obstetrics, gynecology, urology, internal medicine, and pediatrics medical services; ambulatory surgery center facilities services; and ancillary medical services. Further, it provides pre-implantation genetic screening testing, management consultancy, postpartum and rehabilitation care, maternal-child nursing, and other hospital- derived services. Additionally, the company is involved in property investment, and real estate development and operation activities; sale of medicines, consumables, and equipment; research and development of IVF related projects, including scientific research and related commercialization; and operates restaurant. Jinxin Fertility Group Limited was founded in 1951 and is headquartered in Chengdu, China.
Side-by-side comparison against top Healthcare peers.